2021 - Early Therapeutic Antibody Development: Addressing the Challenges to Expedite a CMC Program
Date2021-07-15
Deadline2021-07-15
VenueXtalks, Canada
KeywordsMonoclonal Antibodies; Therapeutic Antibody Dev; Synthetic Chemistry
Topics/Call fo Papers
Recommendations to prevent a drug development program from becoming a failure statistic
Understanding how to select variants that give you the best chance of manufacturing success
Discovering options for reducing timelines, whilst also mitigating risk
For More Information Please Visit: https://xtalks.com/webinars/early-therapeutic-anti...
Understanding how to select variants that give you the best chance of manufacturing success
Discovering options for reducing timelines, whilst also mitigating risk
For More Information Please Visit: https://xtalks.com/webinars/early-therapeutic-anti...
Other CFPs
- Accelerating Lupus Drug Discovery & Development: Fireside Chat with Experts in SLE Research
- Process Development: Getting from Phase I to III
- Modernizing Neuroscience Clinical Trials Using a Virtual Framework: A Perspective on Endpoint Measurement and Best Practices
- Empowerment Model: A New Partnership Model for Maximum Efficiency, Cost Savings, and Control
- Combination Drug Products: A Development Roadmap to Clinical Trials
Last modified: 2021-06-24 22:42:04